Vyant Bio Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Andy LaFrence

Chief executive officer

US$463.4k

Total compensation

CEO salary percentage70.1%
CEO tenure3.8yrs
CEO ownership0.2%
Management average tenureno data
Board average tenure2.6yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Andy LaFrence's remuneration changed compared to Vyant Bio's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2023n/an/a

-US$13m

Mar 31 2023n/an/a

-US$16m

Dec 31 2022US$463kUS$325k

-US$16m

Sep 30 2022n/an/a

-US$16m

Jun 30 2022n/an/a

-US$16m

Mar 31 2022n/an/a

-US$16m

Dec 31 2021US$753kUS$244k

-US$19m

Sep 30 2021n/an/a

-US$17m

Jun 30 2021n/an/a

-US$17m

Mar 31 2021n/an/a

-US$14m

Dec 31 2020n/an/a

-US$9m

Sep 30 2020n/an/a

-US$9m

Jun 30 2020n/an/a

-US$8m

Mar 31 2020n/an/a

-US$9m

Dec 31 2019US$308kUS$80k

-US$9m

Compensation vs Market: Andy's total compensation ($USD463.36K) is about average for companies of similar size in the German market ($USD418.12K).

Compensation vs Earnings: Andy's compensation has been consistent with company performance over the past year.


CEO

Andy LaFrence (60 yo)

3.8yrs

Tenure

US$463,364

Compensation

Mr. Andrew D.C. LaFrence, CPA, also known as Andy, served as Chief Financial Officer at KORU Medical Systems, Inc. since July 10, 2023 until July 27, 2023. He serves as President & CEO of Vyant Bio, Inc. s...


Board Members

NamePositionTenureCompensationOwnership
Yung-Ping Yeh
Co-Founder & Director2.4yrsUS$22.50k4.33%
€ 42.4k
Joanna Horobin
Independent Director2.4yrsUS$108.87k0.20%
€ 2.0k
R. Fletcher
Independent Chairman of the Board2.4yrsUS$139.98k0.40%
€ 4.0k
John Roberts
Director2.6yrsUS$513.95k0.13%
€ 1.2k
Howard McLeod
Independent Director9.6yrsUS$103.13k0.14%
€ 1.4k
Geoffrey Harris
Independent Director9.6yrsUS$111.19k0.20%
€ 2.0k
Paul Hansen
Independent Director2.6yrsUS$98.53k2.33%
€ 22.8k

2.6yrs

Average Tenure

61yo

Average Age

Experienced Board: 1C80's board of directors are not considered experienced ( 2.6 years average tenure), which suggests a new board.